Lapsed May 30, 2025 on the fee record · Medium confidence
20-year base term ends Dec 8, 2031
Why Medium: The disclaimer's references carry disclaimers of their own not yet read (US 9,242,936), so the cap could be lower.
Second maintenance fee unpaid; grace period ended.
Dec 8, 2011
May 30, 2025
May 30, 2017
Dec 8, 2031
Its term would have run to Dec 8, 2031: its 20-year base term, with no adjustment for prosecution delay. A terminal disclaimer is resolved from the filed document, and it ends no earlier than this term, so it shortens nothing. Confidence: Medium. from the record
How we calculated this date
| Step | Input | Date after this step | Confidence |
|---|---|---|---|
| Base term, 20 years from filing | Clock starts Dec 8, 2011, when application 13/315,005, the earliest non-provisional in its chain, was filed (this one was filed Dec 15, 2015) | Dec 8, 2031 | High confidence |
| Continuity chain | Every parent in the chain resolved | no change | High confidence |
| Patent term adjustment | None on file | no change | High confidence |
| Terminal disclaimer cap | Disclaimer resolved from the filed document (refs US 8,598,362, US 9,242,936) | resolves to Dec 8, 2031, no earlier than this term, so no change | Medium confidence |
| Patent term extension | None on file | no change | High confidence |
| Fee events | 1 of 3 maintenance fees paid | lapsed May 30, 2025 | High confidence |
| Computed term end | The steps above, in order | May 30, 2025 | Medium confidence |
This family
| US 8,598,362 | Lapsed on the fee record Dec 2025 | Dec 2025 |
| US 8,921,566 | In force Dec 2031 | Dec 2031 |
| US 9,242,936 | In force no later than Dec 2031 | no later than Dec 2031 |
| US 9,663,492 | this patent May 2025 | May 2025 |
| US 10,112,925 | Lapsed on the fee record Oct 2026 | Oct 2026 |
Assignments
| Recorded | Assignor | Assignee | Conveyance |
|---|---|---|---|
| Dec 15, 2015 Reel 37296, frame 528 | Li, Wei; Zhao, Robert Yongxin | ImmunoGen, Inc. | Assignment of Assignor's Interest |
| Apr 6, 2023 Reel 63282, frame 894 | ImmunoGen, Inc.; ImmunoGen Switzerland GmbH | Biopharma Credit PLC | Patent Security Agreement |
| Feb 12, 2024 Reel 66553, frame 109 | Biopharma Credit PLC | ImmunoGen, Inc.; ImmunoGen Switzerland GmbH | Release of Security Interest |
| Feb 12, 2024 reel/frame not recorded | Biopharma Credit PLC | ImmunoGen, Inc. | Release of Security Interest |
| Feb 12, 2024 reel/frame not recorded | Biopharma Credit PLC | ImmunoGen Switzerland GmbH | Release of Security Interest |
Sources
Google Patents · The patent document at USPTO · Assignment records at USPTO
USPTO account required: This application in Patent Center · USPTO's maintenance fee lookup
Maintenance fee events come from USPTO's own fee records. Its fee lookup asks for the patent number and the application number.
A terminal disclaimer resolved from the filed document, referencing US 8,598,362, US 9,242,936, ends no earlier than this term, so it caps nothing.